Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria therapy in endemic countries worldwide. This systematic review aims at presenting the current scenario of drug resistance molecular markers, either selected or involved in treatment failures (TF) during in vivo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Parasitol Drugs Drug Resist
Autori principali: Arya, Aditi, Kojom Foko, Loick P., Chaudhry, Shewta, Sharma, Amit, Singh, Vineeta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Regular article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887327/
https://ncbi.nlm.nih.gov/pubmed/33556786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2020.11.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi